Search

Your search keyword '"Gorochov, Guy"' showing total 538 results

Search Constraints

Start Over You searched for: Author "Gorochov, Guy" Remove constraint Author: "Gorochov, Guy"
538 results on '"Gorochov, Guy"'

Search Results

1. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

3. Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

5. Cytokine profile of anti-spike CD4+T cells predicts humoral and CD8+T cell responses after anti-SARS-CoV-2 mRNA vaccination

6. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

8. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

9. Intestinal Candida albicans overgrowth in IgA deficiency

10. Monoclonal antibody-mediated neutralization of SARS-CoV-2 in an IRF9-deficient child

11. Phenotypic Heterogeneity of Fulminant COVID-19--Related Myocarditis in Adults

12. Identification of bronchoalveolar and blood immune-inflammatory biomarker signature associated with poor 28-day outcome in critically ill COVID-19 patients

13. Auto-antibodies against type I IFNs in > 10% of critically ill COVID-19 patients: a prospective multicentre study

14. Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis

15. Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination

16. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

17. A comparison of Sars-Cov-2 vaccine platforms: the CoviCompare project

19. Anti-S-layer monoclonal antibodies impact Clostridioides difficile physiology

21. Synergistic convergence of microbiota-specific systemic IgG and secretory IgA

22. Cytokine profile of anti-spike CD4+T cells predicts humoral and CD8+T cell responses after anti-SARS-CoV-2 mRNA vaccination

23. Anti-S-layer monoclonal antibodies impactC. difficilephysiology

24. A monoclonal antibody collection forC. difficiletyping

25. Identification of natural killer markers associated with fatal outcome in COVID-19 patients

27. Data from The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals

28. Supplementary Data from The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals

29. Supplementary Figure from The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals

30. Inherited and acquired errors of type I interferon immunity govern susceptibility to COVID-19 and multisystem inflammatory syndrome in children

31. JAK inhibitors for the treatment of adult dermatomyositis: A pilot study

34. T-independent responses to polysaccharides in humans mobilize marginal zone B cells prediversified against gut bacterial antigens

35. Anti-PD-1 immune-related adverse events are associated with high therapeutic antibody fixation on T cells

36. Additional file 1 of Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

37. Lower disease activity but higher risk of severe COVID-19 and herpes zoster in systemic lupus erythematosus patients with pre-existing autoantibodies neutralising IFN-α

39. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

40. Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis

45. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

46. Suppressive activity of human regulatory T cells is maintained in the presence of TNF

47. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

49. Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α

50. Multimodal single cell analysis reveals the basis for butyrate induction of TNFα-secreting regulatory T cells

Catalog

Books, media, physical & digital resources